Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 708 of 1,261
  1. US 9266856

    AMPK—activating heterocyclic compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  2. US 9266813

    Stilbenoid compound as inhibitor for squamous carcinoma and hepatoma and uses thereof

    China Medical University · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  3. US 9266843

    Nuclear transport modulators and uses thereof

    Karyopharm Therapeutics Inc. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  4. US 9265828

    Hydrogel implants with varying degrees of crosslinking

    Covidien LP · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  5. US 9265827

    Anti-PDGFR-beta antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  6. US 9265818

    Genetically modified Babesia parasites expressing protective tick antigens and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  7. US 9265759

    Compositions and methods of treating retinal disease

    Aldeyra Therapeutics, Inc. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  8. US 9265749

    Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders

    Patara Pharma, LLC · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  9. US 9265734

    Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  10. US 9265730

    Stable solid preparations

    Takeda Pharmaceutical Company Limited · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  11. US 2016045495

    ARIPIPRAZOLE PRODRUG COMPOSITIONS

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Feb 18, 2016 · Expires Feb 13, 2036

    granted
  12. US 9259463

    Chlamydia vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  13. US 9259452

    Deacetylase inhibitor therapy

    THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  14. US 9260416

    Heterocyclic autotaxin inhibitors and uses thereof

    AMIRA PHARMACEUTICALS, INC. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  15. US 9260515

    Antibodies to human GDF8

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  16. US 9260752

    Compositions and methods of nucleic acid-targeting nucleic acids

    Caribou Biosciences, Inc. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  17. US 9259453

    Use of salmonella flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases

    Institute of Radiation Medicine, Academy of Military Medical Sciences, People's Liberation Army of China · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  18. US 9259414

    Glycopyrrolate salts

    Dermira, Inc. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  19. US 9259407

    Nanoemulsion therapeutic compositions and methods of using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  20. US 9259386

    Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  21. US 9261507

    Anti CEACAM1 antibodies and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  22. US 9260726

    Targeted integration and expression on exogenous nucleic acid sequences

    Sangamo Biosciences, Inc. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  23. US 9260718

    Compositions and methods for inhibiting expression of the PCSK9 gene

    Alnylam Pharmaceuticals, Inc. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  24. US 9260511

    Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of IsaA or IsaB

    Julius-Maximilians-Universitat Wurzburg · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.